Stanford Movement Disorders Center News

Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson’s disease progression

A study led by Andreas Keller, visiting faculty at Stanford, along with Kathleen Poston and Tony Wyss-Coray, reports the longitudinal profiling of circulating small noncoding RNAs in the blood of patients with Parkinson's and identifies several microRNAs as potential diagnostic and prognostic biomarkers.

Safety of Plasma Infusions in Parkinson's Disease

The International Parkinson and Movement Disorder Society (MDS) has ranked our article as the top Movement Disorders article of July 2020.

How hacking the human heart could replace pill popping

A new generation of “smart” implantable devices could replace traditional medication to treat a range of chronic conditions, including cardiac disease. Twitter: @geditorial_uk

Addressing Neuropsychiatric Symptoms in Huntington Disease: Expert Interview

Veronica Santini, MD discusses neuropsychiatric symptoms associated with Huntington Disease with Neurology Advisor.

Stanford announces new Lewy Body Dementia (LBD) Research Center of Excellence

In December 2017 researchers from across the country joined in the first-ever comprehensive network of research centers to conduct LBD clinical trials, provide community outreach, and expand professional continuing medical education. Representing 24 of medicine’s most prestigious academic medical research centers, these Research Centers of Excellence will help to streamline and standardize LBD science while connecting patients and families with the latest opportunities to participate in LBD clinical trials.

Complementary Therapies for Parkinson's Disease

Veronica Santini, MD emphasizes complementary and alternative therapies in Parkinson's disease, including vitamin E. She also discusses the importance of exercise in the overall spectrum of care.

Parkinson's patients take to the dance floor

Finding the rhythm is half the fun of dancing, but it takes a little more effort when your body is wracked by Parkinson's Disease. But in a brand new dance studio at Stanford's Neuroscience Health Center, patients are able to hit the floor with the help of professional dancer Damara Vita Ganley and a program designed to help them get in touch with their bodies.

You, Your Loved One and Parkinson's Disease

What is the difference between an observational trial and an interventional trial?  Why do people without Parkinson’s disease need to participate in Parkinson’s disease clinical trials? In an interview with the Michael J. Fox Foundation, Dr. Kathleen Poston answers these questions and more as she discusses what it means to part of clinical research. (Login required to view video)